Were Patrick Cunningham’s Aveanna Healthcare (AVAH) share sales part of a broader trading plan?

The filing states the transactions were part of aggregate sales by Aveanna’s stock plan administrator. They were executed to cover tax liabilities from vested equity awards, indicating an administrative process rather than a discretionary trading strategy.

Aveanna (AVAH) CCO logs 49,160-share automatic tax-related sale

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported automatic sales of common stock to cover taxes on vested equity awards. Over February 17–19, 2026, he sold a total of 49,160 shares in open-market transactions at weighted average prices ranging from $7.06 to $7.97 per share, as part of aggregate sales handled by the company’s stock plan administrator. Following these sales, he directly holds 337,755 shares of Aveanna common stock.

Insider Trade Summary

Net Seller: 49,160 shares

Net Sell 3 txns

Insider Cunningham Patrick A.

Role Chief Compliance Officer

Sold 49,160 shs ($363K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	18,436	$7.2082	$133K
Sale	Common Stock, par value $0.01 per share	17,965	$7.3829	$133K
Sale	Common Stock, par value $0.01 per share	12,759	$7.6451	$98K

Holdings After Transaction: Common Stock, par value $0.01 per share — 337,755 shares (Direct)

Footnotes (4)

F1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
F2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/19/2026 - 09:15 PM

FAQ

What insider transaction did Aveanna Healthcare (AVAH) report for Patrick Cunningham?

Aveanna Healthcare reported that Chief Compliance Officer Patrick A. Cunningham sold 49,160 common shares. The transactions occurred between February 17 and 19, 2026, as automatic sales tied to tax obligations from previously vested equity awards.

Why did Patrick Cunningham sell Aveanna Healthcare (AVAH) shares on this Form 4?

The shares were automatically sold to satisfy Patrick Cunningham’s tax obligations on stock received from vested equity awards. These sales were executed by the company’s stock plan administrator rather than through a discretionary open-market trading decision.

How many Aveanna Healthcare (AVAH) shares did Patrick Cunningham sell and at what prices?

Patrick Cunningham sold a total of 49,160 Aveanna common shares. The weighted average sale prices for the reported trades ranged between $7.06 and $7.97 per share, with detailed price breakdowns available upon request from the issuer or regulators.

How many Aveanna Healthcare (AVAH) shares does Patrick Cunningham hold after the reported sales?

After the reported transactions, Patrick Cunningham directly holds 337,755 shares of Aveanna common stock. This figure reflects his remaining ownership following the automatic tax-related sales disclosed in the Form 4 filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Patrick A.

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/17/2026		S⁽¹⁾		12,759	D	$7.6451⁽²⁾	374,156	D
Common Stock, par value $0.01 per share	02/18/2026		S⁽¹⁾		17,965	D	$7.3829⁽³⁾	356,191	D
Common Stock, par value $0.01 per share	02/19/2026		S⁽¹⁾		18,436	D	$7.2082⁽⁴⁾	337,755	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.

2. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR